WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS

This group comprises all drugs for obstructive airway diseases for inhalation excl. adrenergics (R03A).

See comment under R03A.


R03BA Glucocorticoids

Combinations with adrenergics are classified in R03AK.
The combination of ciclosonide and tiotropium bromide is classified in R03BB54.
Fluticasone propionate is classified in R03BA05.


The DDDs are based on the starting dose in moderate to severe asthma.

R03BB Anticholinergics

Combinations with adrenergics are classified in R03AL.
The combination of tiotropium bromide and ciclosonide is classified in R03BB54.

The DDDs are based on the maintenance treatment of asthma.
The DDDs for tiotropium bromide and umeclidinium bromide are based on treatment of COPD (Chronic Obstructive Pulmonary Disease).
The DDD for tiotropium bromide inhalation powder is based on tiotropium, delivered dose.
The DDD for aclidinium bromide inhalation powder is based on aclidinium, delivered dose.
The DDD for glycopyrronium bromide inhalation powder is based on glycopyrronium, delivered dose.

The DDD for umeclidinium bromide inhalation powder is based on umeclidinium, delivered dose.

R03BC Antiallergic agents, excl. corticosteroids

The DDDs are based on the prophylaxis of asthma.
DDD for inhalation aerosol and inhalation powder differ in this group, due to differences in dosage recommendations for these dosage forms.

R03BX Other drugs for obstructive airway diseases, inhalants

Last updated: 2024-01-26